Evaluation of insulin expression and secretion in genetically engineered gut K and L-cells

BMC Biotechnology

Volumn 12, Issue , 2012, Pages

  Ahmad, Zalinah ^a   Rasouli, Mina ^a   Azman, Ahmad Zaid F ^a   Omar, Abdul R ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Diabetes gene therapy; Insulin expression; K cells; L cells

Indexed keywords

CELL TYPES; ENZYME LINKED IMMUNOSORBENT ASSAY; IN-VITRO; INSULIN GENE; INSULIN SECRETION; K-CELLS; L-CELLS; RECOMBINANT PLASMID; TISSUE TYPES;

CYTOLOGY; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; GLUCOSE; INSULIN; MEATS; PHYSIOLOGY;

CELLS;

GLUCOSE; INSULIN;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL TYPE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; GENETIC TRANSFECTION; IN VITRO STUDY; INSULIN RELEASE; INTESTINE CELL; KILLER CELL; L CELL; NONHUMAN; PROTEIN EXPRESSION; RECOMBINANT PLASMID;

ANIMALS; CELL SEPARATION; GENE EXPRESSION; GENETIC ENGINEERING; GLUCOSE; INSULIN; INTESTINES; L CELLS (CELL LINE); MICE;

EID: 84866272024     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-12-64     Document Type: Article

References (28)

1. Peek ME, Cargill A, Huang ES. Diabetes health disparities: a systematic review of health care interventions. Med Care Res Rev 2007, 64(5 Suppl):101S-156S. 10.1177/1077558707305409, 2367214, 17881626.
2. Yoon JW, Jun HS. Recent advances in insulin gene therapy for type 1 diabetes. Trends Mol Med 2002, 8(2):62-68. 10.1016/S1471-4914(02)02279-7, 11815271.
3. Samson SL, Chan L. Gene therapy for diabetes: reinventing the islet. Trends Endocrinol Metab 2006, 17(3):92-100. 10.1016/j.tem.2006.02.002, 16504534.
4. Falqui L, Martinenghi S, Severini GM, Corbella P, Taglietti MV, Arcelloni C, Sarugeri E, Monti LD, Paroni R, Dozio N, et al. Reversal of diabetes in mice by implantation of human fibroblasts genetically engineered to release mature human insulin. Hum Gene Ther 1999, 10(11):1753-1762. 10.1089/10430349950017437, 10446915.
5. Motoyoshi S, Shirotani T, Araki E, Sakai K, Kaneko K, Motoshima H, Yoshizato K, Shirakami A, Kishikawa H, Shichiri M. Cellular characterization of pituitary adenoma cell line (AtT20 cell) transfected with insulin, glucose transporter type 2 (GLUT2) and glucokinase genes: insulin secretion in response to physiological concentrations of glucose. Diabetologia 1998, 41(12):1492-1501. 10.1007/s001250051096, 9867217.
6. Yin D, Tang JG. Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA into skeletal muscle in vivo. FEBS Lett 2001, 495(1-2):16-20.
7. Chen R, Meseck ML, Woo SL. Auto-regulated hepatic insulin gene expression in type 1 diabetic rats. Mol Ther 2001, 3(4):584-590. 10.1006/mthe.2001.0299, 11319921.
8. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007, 132(6):2131-2157. 10.1053/j.gastro.2007.03.054, 17498508.
9. Deacon CF. What do we know about the secretion and degradation of incretin hormones?. Regul Pept 2005, 128(2):117-124. 10.1016/j.regpep.2004.06.007, 15780431.
10. Theodorakis MJ, Carlson O, Michopoulos S, Doyle ME, Juhaszova M, Petraki K, Egan JM. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am J Physiol Endocrinol Metab 2006, 290(3):E550-559.
11. Vilsboll T, Krarup T, Madsbad S, Holst JJ. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects. Regul Pept 2003, 114(2-3):115-121.
12. Gautier JF, Fetita S, Sobngwi E, Salaun-Martin C. Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes. Diabetes Metab 2005, 31(3 Pt 1):233-242.
13. Green BD, Flatt PR. Incretin hormone mimetics and analogues in diabetes therapeutics. Best Pract Res Clin Endocrinol Metab 2007, 21(4):497-516. 10.1016/j.beem.2007.09.003, 18054732.
14. Seidah NG, Chretien M, Day R. The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions. Biochimie 1994, 76(3-4):197-209.
15. Lynch DR, Strittmatter SM, Venable JC, Snyder SH. Enkephalin convertase in the gastrointestinal tract an associated organs characterized and localized with [3H]guanidinoethylmercaptosuccinic acid. Endocrinology 1987, 121(1):116-126. 10.1210/endo-121-1-116, 3109877.
16. Cheung AT, Dayanandan B, Lewis JT, Korbutt GS, Rajotte RV, Bryer-Ash M, Boylan MO, Wolfe MM, Kieffer TJ. Glucose-dependent insulin release from genetically engineered K cells. Science 2000, 290(5498):1959-1962. 10.1126/science.290.5498.1959, 11110661.
17. Ramshur EB, Rull TR, Wice BM. Novel insulin/GIP co-producing cell lines provide unexpected insights into Gut K-cell function in vivo. J Cell Physiol 2002, 192(3):339-350. 10.1002/jcp.10139, 12124779.
18. Han J, Lee HH, Kwon H, Shin S, Yoon JW, Jun HS. Engineered enteroendocrine cells secrete insulin in response to glucose and reverse hyperglycemia in diabetic mice. Mol Ther 2007, 15(6):1195-1202.
19. Tang SC, Sambanis A. Development of genetically engineered human intestinal cells for regulated insulin secretion using rAAV-mediated gene transfer. Biochem Biophys Res Commun 2003, 303(2):645-652. 10.1016/S0006-291X(03)00399-1, 12659868.
20. Bara H, Sambanis A. Insulin-secreting L-cells for the treatment of insulin-dependent diabetes. Biochem Biophys Res Commun 2008, 371(1):39-43. 10.1016/j.bbrc.2008.03.154, 2698788, 18406351.
21. Tang SC, Sambanis A. Differential rAAV2 transduction efficiencies and insulin secretion profiles in pure and co-culture models of human enteroendocrine L-cells and enterocytes. J Gene Med 2004, 6(9):1003-1013. 10.1002/jgm.587, 15352073.
22. Rasouli M, Ahmad Z, Omar AR, Allaudin ZN. Engineering an L-cell line that expresses insulin under the control of the glucagon-like peptide-1 promoter for diabetes treatment. BMC Biotechnol 2011, 11(1):99. 10.1186/1472-6750-11-99, 3229441, 22047106.
23. Boylan MO, Jepeal LI, Jarboe LA, Wolfe MM. Cell-specific expression of the glucose-dependent insulinotropic polypeptide gene in a mouse neuroendocrine tumor cell line. J Biol Chem 1997, 272(28):17438-17443. 10.1074/jbc.272.28.17438, 9211887.
24. Gosmain Y, Avril I, Mamin A, Philippe J. Pax-6 and c-Maf functionally interact with the alpha-cell-specific DNA element G1 in vivo to promote glucagon gene expression. J Biol Chem 2007, 282(48):35024-35034. 10.1074/jbc.M702795200, 17901057.
25. Rindi G, Grant SG, Yiangou Y, Ghatei MA, Bloom SR, Bautch VL, Solcia E, Polak JM. Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression. Am J Pathol 1990, 136(6):1349-1363. 1877573, 2162628.
26. Amos PJ, Cagavi Bozkulak E, Qyang Y. Methods of cell purification: a critical juncture for laboratory research and translational science. Cells Tissues Organs 2012, 195(1-2):26-40.
27. Schirra J, Katschinski M, Weidmann C, Schafer T, Wank U, Arnold R, Goke B. Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 1996, 97(1):92-103. 10.1172/JCI118411, 507066, 8550855.
28. Burcelin R. The incretins: a link between nutrients and well-being. Br J Nutr 2005, 93(Suppl 1):S147-S156.